Media coverage
7
Media coverage
Title Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet Street Insider Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet Market News Publishing Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet InvestorsObserver Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet Yahoo! Finance Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet Chase Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title Sona’s ‘THT’ Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet Health Technology Net Country/Territory United States Date 9/11/23 Persons Carman Anthony Giacomantonio Title Sona Nanotech Inc.: Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 9/11/23 Persons Carman Anthony Giacomantonio